New Delhi, Jul 15 (PTI) Glenmark Pharmaceuticals has received final approval from the US health regulator for its generic Fluocinonide cream used for treating a variety of skin infections. Glenmark Generics Inc USA, the subsidiary of Glenmark ... Press Trust of India, 1 month ago
Glenmark Generics receives final ANDA approval for Fluocinonide cream - Moneycontrol.com, 1 month ago
Glenmark's fluocinonide cream receives US FDA approval - PharmaBiz, 1 month ago
Case Name: Sanofi-Aventis Deutschland GmBH v. Glenmark Pharms Inc. , 748 F.3d 1354 (Fed. Cir. Apr. 21, 2014) (Circuit Judges Newman, Linn and Wallach presiding; Opinion by Newman) (Appeal from D.N.J., Cavanaugh, J.) Drug Product and ...JD Supra, 1 month ago GLENMARK PHARMACEUTICALS : Gets nod for skin infection cream 4 Traders, 1 month ago GLENMARK GETS NOD FOR SKIN INFECTION CREAM Pharmacy Choice, 1 month ago
The facility will be situated in Monroe, North Carolina, USA The facility will manufacture oral solids, injectables and topicals over a five year period Mumbai, India; July 17, 2014: Glenmark Pharmaceuticals Ltd; a research-driven, global, ...FiercePharmaManufacturing, 3 weeks ago Glenmark to set up production unit in U.S. The Hindu, 1 month ago Glenmark plans to set up new facility in US Hindu Business Line, 1 month ago Glenmark to set up first manufacturing facility in US Business Standard India, 1 month ago
/PRNewswire/ -- Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights -- India Business grew by 20.87% to Rs. 3,971.59 Mn -- US Business grew by 9.33% to Rs. 4,886.70 Mn -- Rest of World (ROW) Business grew by ...Scottrade, 1 month ago Glenmark net profit surges by 43.7% in Q1 PharmaBiz, 1 month ago
Glenmark Pharma soars on entering Oncology with discovery of IND enabling studies of innovative b...
Glenmark Pharmaceuticals is currently trading at Rs. 736.50, up by 17.05 points or 2.37% from its previous closing of Rs. 719.45 on the BSE. The scrip opened at Rs. 726.00 and has touched a high and low of Rs. 749.05 and Rs. 726.00 respectively.Arihant Capital, 1 week ago Glenmark Pharma enters Oncology with discovery of IND enabling studies of innovative bispecific antibody Indian-Commodity, 1 week ago
Glenmark Pharmaceuticals is currently trading at Rs. 565.95, up by 1.40 points or 0.25% from its previous closing of Rs. 564.55 on the BSE. The scrip opened at Rs. 564.60 and has touched a high and low of Rs. 568.00 and Rs. 558.50 respectively. So ...Arihant Capital, 1 month ago Glenmark Pharma surges on plan to set up new manufacturing facility in US Arihant Capital, 1 month ago
Glenmark Pharmaceuticals is currently trading at Rs 546.25, up by 7.10 points or 1.32% from its previous closing of Rs. 539.15 on the BSE. The scrip opened at Rs 542.00 and has touched a high and low of Rs 557.00 and Rs. 542.00 respectively. So ...Arihant Capital, 1 month ago Glenmark Pharmaceuticals gains as its arm receives final ANDA approval for Telmisartan Tablets Arihant Capital, 1 month ago
provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential ...MarketResearch.com, 2 months ago
The Bombay Stock Exchange healthcare index of 17 leading pharmaceutical companies has outperformed BSE Sensex of 30 companies during August 2014. BSE healthcare index improved sharply by 8.2 per cent and closed at 13356.87 as compared to12341.28 as ...PharmaBiz, 11 hours ago
Key benchmark indices dropped as caution prevailed ahead of the release of minutes from the US Federal Reserve's latest meeting. The barometer index, the S&P BSE Sensex, hit its lowest closing level in almost a week. The Sensex shed 106.38 points or ...Business Standard India, 1 week ago
on your WebpageAdd Widget >Get your members hooked!